Table 2.
Variables | Training Set | Test Set | p-Value |
---|---|---|---|
Sex (female) | 79.6% | 79.9% | 0.584 |
Age | 77.2 ± 0.18 | 77.2 ± 0.28 | 0.834 |
Body Mass Index | 21.6 ± 0.06 | 21.8 ± 0.13 | 0.975 |
Primary fracture site | |||
Proximal part of the femur | 73.6% | 73.9% | 0.837 |
Proximal part of the humerus | 6.3% | 6.1% | 0.895 |
Distal part of the radius | 19.9% | 20.1% | 0.758 |
Diabetes | 19.6% | 18.8% | 0.459 |
Chronic kidney disease | 21.6% | 21.5% | 0.915 |
Rheumatoid arthritis | 2.7% | 2.5% | 0.785 |
Chronic obstructive pulmonary disease | 3.8% | 4.1% | 0.588 |
Presence of malignant tumor | 12.5% | 11.1% | 0.077 |
Glucocorticoid use | 2.8% | 2.7% | 0.758 |
Warfarin use | 5.0% | 5.5% | 0.333 |
Pre-operative Ca or Vit. D | 6.0% | 6.7% | 0.262 |
Pre-operative treatments for osteoporosis | 7.9% | 8.0% | 0.803 |
Post-operative Ca or Vit. D | 12.9% | 12.4% | 0.63 |
Post-operative treatments for osteoporosis | 28.7% | 28.6% | 0.92 |
Follow-ups more than 24 months | 39.3% | 39.0% | 0.781 |
Data presented as mean (standard error of the mean). Ca: calcium; Vit. D: vitamin D3.